<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cardiophile MD Archive &#187; Angiography and Interventions</title>
	<atom:link href="http://www.cardiophile.net/category/angiography-and-interventions/feed" rel="self" type="application/rss+xml" />
	<link>http://www.cardiophile.net</link>
	<description>Archive of Cardiophile MD</description>
	<lastBuildDate>Wed, 16 Jun 2010 00:06:48 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
		<item>
		<title>Guiding PCI with fractional flow reserve (FFR)</title>
		<link>http://www.cardiophile.net/2010/05/guiding-pci-with-fractional-flow-reserve-ffr.html</link>
		<comments>http://www.cardiophile.net/2010/05/guiding-pci-with-fractional-flow-reserve-ffr.html#comments</comments>
		<pubDate>Fri, 28 May 2010 14:23:57 +0000</pubDate>
		<dc:creator>Johnson Francis</dc:creator>
				<category><![CDATA[Angiography and Interventions]]></category>
		<category><![CDATA[Coronary]]></category>

		<guid isPermaLink="false">http://cardiophile.org/?p=4693</guid>
		<description><![CDATA[Coronary angiography gives a visual impression about the severity of the stenosis. But it need not imply the actual functional significance of the stenosis in terms of flow physiology. It is often difficult to decide which are the flow limiting lesions when there are multiple stenoses in same or different territories. It is here that [...]]]></description>
			<content:encoded><![CDATA[<p>Coronary angiography gives a visual impression about the severity of the stenosis. But it need not imply the actual functional significance of the stenosis in terms of flow physiology. It is often difficult to decide which are the flow limiting lesions when there are multiple stenoses in same or different territories. It is here that the fractional flow reserve estimation helps. Fractional flow reserve (FFR) is estimated using a guide wire with a pressure transducer. Current FFR wires have properties similar to the floppy guide wires so that they can passed across coronary lesions back and forth easily to assess the pressure drop across the lesions. The flow reserve is calculated after inducing maximal hyperemia in the distal territory with intracoronary adenosine or papaverine or intravenous adenosine given in a central vein. FFR is obtained by dividing the pressure distal to the stenosis by the central aortic pressure, which is usually equal to the pressure proximal to the stenosis if there is no additional stenosis in between. Normal FFR is 1.0 and an FFR below 0.75 indicates inducible ischemia while an FFR above 0.80 excludes ischemia in 90% of cases. So it is evident that the grey zone in FFR evaluation is very limited. FFR measurement is successful in almost 99% of cases and the values are reproducible. If the FFR normalises after stenting, the restenosis rates at six months is less than 5%. Since the FFR wire can be used for guiding balloon catheters and stents, it is easy to make post procedure measurements without any additional effort. When there multiple stenosis, the wire will pick up the pressure drop at each lesion so that we can decide on which all lesions are significant and needs tackling.</p>
<p>A recent study published in <a href="http://content.onlinejacc.org/cgi/content/full/j.jacc.2010.04.012v1#BIB4">JACC</a> evaluated the two year results of FFR guided PCI (percutaneous coronary intervention). Pijls NHJ et al reported the two year follow up of the FAME  (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study which had shown that FFR improves the outcome of PCI at one year. The study involved over one thousand patients with multi vessel coronary artery disease randomized to PCI with either angiographic guidance alone or with FFR in addition. In the angiography alone guided group, the decision for stent was depending on the visual appearance of the lesion. In the FFR guided group, stents were deployed only for the lesions which showed and FFR of 0.80 or less. The other lesions were left on medical management. Naturally the FFR guided group received lesser number of stents. They had lower rates of mortality or myocardial infacrtion. PCI or coronary artery bypass surgery rates were also lower, though not statistically significant. The lesions deferred on basis of FFR had only a 0.2% myocardial infarction rate and 3.2% revascularization rate.  A downside of the study was that it had included lesions of 50 to 79% stenosis also. But the author justify their decision mentioning that 35% of these lesions were hemodynamically significant and leaving them untreated based on angiographic appearance alone would not have been ideal. Another potential draw back of the data is that theoretically the lesions left alone based on FFR can also progress beyond the study period of two years and present later with significant stenosis.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cardiophile.net/2010/05/guiding-pci-with-fractional-flow-reserve-ffr.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Carotid stenting or endarterectomy?</title>
		<link>http://www.cardiophile.net/2010/05/carotid-stenting-or-endarterectomy.html</link>
		<comments>http://www.cardiophile.net/2010/05/carotid-stenting-or-endarterectomy.html#comments</comments>
		<pubDate>Thu, 27 May 2010 04:16:54 +0000</pubDate>
		<dc:creator>Johnson Francis</dc:creator>
				<category><![CDATA[Angiography and Interventions]]></category>
		<category><![CDATA[Carotid]]></category>
		<category><![CDATA[Journal Update]]></category>

		<guid isPermaLink="false">http://cardiophile.org/?p=4691</guid>
		<description><![CDATA[A recent study by Brott GT et al for the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) Investigators published in NEJM compared carotid stenting with endarterectomy. The trial was unique in that it involved both symptomatic and asymptomatic patients with carotid stenosis and there was strict credentialing for both surgeons and interventionalists for inclusion as [...]]]></description>
			<content:encoded><![CDATA[<p>A recent study by Brott GT et al for the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) Investigators published in <a href="http://content.nejm.org/cgi/content/full/NEJMoa0912321?query=TOC">NEJM</a> compared carotid stenting with endarterectomy. The trial was unique in that it involved both symptomatic and asymptomatic patients with carotid stenosis and there was strict credentialing for both surgeons and interventionalists for inclusion as study operators. It is interesting to note that over a median follow up period of two and a half years, there was no significant difference in the estimated four year primary end point rates in over two thousand five hundred study patients. The primary end point was a composite of stroke, myocardial infarction or death from any cause during the periprocedural period of about one month or ipsilateral stroke within four years after randomization.</p>
<p>But there was higher risk of stroke during the periprocedural period in the stenting group and higher risk of myocardial infarction with endarterectomy. After that period, the events were similar in both groups.</p>
<p>Symptoms considered for inclusion in the symptomatic group were transient ischemic attack, amaurosis fugax or minor non-disabling stroe in the carotid territory within 6 months before randomization. Stenosis required for inclusion was 50% or more angiographic stenosis or 70% or more stenosis on ultrasonography or 70% or more stenosis on CT or MR angiography when ultrasonic stenois was reported between 50 to 69%. The eligibility criteria was different in the asymptomatic group, requiring 60% or more angiographic stenosis, 70% or more ultasonic stenosis or 80% or more stenosis on CT or MR angiographic stenosis when ultrasonic stenosis was 50 to 69%.</p>
<p>Distal protection devices were used for stenting whenever feasible. Aspirin and clopidogrel pretreatment was given prior to stenting and continued afer procedure. Loading dose of aspirin and clopidogrel were given when stenting occurred within 48 hours of randomization. Endarterectomy patients were pretreated with aspirin for at least 48 hours and continued after the procedure. Alternatives for aspirin were ticlopidine, clopidogrel or a combination of aspirin with extended relears dipyridamole.</p>
<p>The authors claim that the rate of stroke or death for the symptomatic patients with carotid stenting in their study was lower than the corresponding rates in the SPACE trial, EVA-3S trial and ICSS. The rate of stroke or death for symptomatic patients with carotid endarterectomy was also lwoer than in SPACE trial and was similar to that in EVA-3S and ICSSS. The rate of stroke or death in the carotid artery stenting group was similar to that in Asymptomatic Carotid Atherosclerosis Study (ACAS) and lower than in Asymptomatic Carotid Surgery Trial (ACST). Corresponding rates were lower for carotid endarterectomy group as well.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cardiophile.net/2010/05/carotid-stenting-or-endarterectomy.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacoinvasive therapy</title>
		<link>http://www.cardiophile.net/2010/05/pharmacoinvasive-therapy.html</link>
		<comments>http://www.cardiophile.net/2010/05/pharmacoinvasive-therapy.html#comments</comments>
		<pubDate>Mon, 24 May 2010 00:26:34 +0000</pubDate>
		<dc:creator>Johnson Francis</dc:creator>
				<category><![CDATA[Angiography and Interventions]]></category>
		<category><![CDATA[congenital]]></category>

		<guid isPermaLink="false">http://cardiophile.org/?p=4668</guid>
		<description><![CDATA[Pharmacoinvasive therapy is the routine early percutaneous coronary intervention (PCI) after thrombolytic therapy. This approach is especially useful when there is a delay in arranging primary PCI due to logistic reasons. The other strategies for combining PCI with thrombolytic therapy are the rescue PCI (ischemia driven PCI) and facilitated PCI. Assent 4 and Finesse trials [...]]]></description>
			<content:encoded><![CDATA[<p>Pharmacoinvasive therapy is the routine early percutaneous coronary intervention (PCI) after thrombolytic therapy. This approach is especially useful when there is a delay in arranging primary PCI due to logistic reasons. The other strategies for combining PCI with thrombolytic therapy are the rescue PCI (ischemia driven PCI) and facilitated PCI. Assent 4 and Finesse trials did not show any benefit with faciliated PCI, possibly because PCI in these trials were undertaken too early, at mean of 74 and 104 minutes of thrombolysis respectively. In this early period, there is increased bleeding tendency and a prothrombotic state which can lead to stent thrombosis. There was also probably an inadequate use of glycoprotein IIb/IIIa receptor inhibitors in these trials. A meta analysis of 23 trials published in Lancet, 2003 comparing PCI with lysis showed a 90% patency of the infarct related artery (IRA) with PCI vs 50 -55% with lytics. Another meta analysis published in American Heart Journal in 2008 showed that death and re infarction was lesser with early PCI after lysis. Transfer AMI is another study which showed the relevance of early PCI after thrombolysis.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cardiophile.net/2010/05/pharmacoinvasive-therapy.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Device closure of ASD in older patients</title>
		<link>http://www.cardiophile.net/2010/05/device-closure-of-asd-in-older-patients.html</link>
		<comments>http://www.cardiophile.net/2010/05/device-closure-of-asd-in-older-patients.html#comments</comments>
		<pubDate>Fri, 21 May 2010 16:14:47 +0000</pubDate>
		<dc:creator>Johnson Francis</dc:creator>
				<category><![CDATA[Angiography and Interventions]]></category>
		<category><![CDATA[congenital]]></category>

		<guid isPermaLink="false">http://cardiophile.org/?p=4660</guid>
		<description><![CDATA[Generally closure of atrial septal defect (ASD) is done in children and young adults. Benefits of device closure of ASD in older patients are not well documented. A recent study involving 23 patients with ASD and aged 50 &#8211; 91 years, having ASD size between 16 to 36 mm reported favorable cardiac remodeling and improvement [...]]]></description>
			<content:encoded><![CDATA[<p>Generally closure of atrial septal defect (ASD) is done in children and young adults. Benefits of device closure of ASD in older patients are not well documented. A <a href="http://interventions.onlinejacc.org/cgi/content/abstract/3/3/276">recent study </a>involving 23 patients with ASD and aged 50 &#8211; 91 years, having ASD size between 16 to 36 mm reported favorable cardiac remodeling and improvement of functional class. The NYHA (New York Heart Association) functional class improved in 16 patients. They had significant improvement in 6 minute walk distance and mental health score. No major complications were noted in these ASD device recipients. They also had significant change in the left ventricular end diastolic and end systolic dimensions at one year after the closure. There was accompanying significant reduction in right ventricular end diastolic dimensions as expected. The improvement of left ventricular function was due to offsetting of the reverse Bernheim effect in which right ventricular dilatation causes a septal bulge and impedance to left ventricular function. Though some studies have shown transient increases in left atrial pressure and consequent pulmonary edema in elderly patients after ASD closure, due to a stiff left ventricle, the current study did not report any such instance. The authors concluded that ASD closure with devices is technically feasible and is associated with favourable cardiac remodeling and improvement in functional class in older patients.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cardiophile.net/2010/05/device-closure-of-asd-in-older-patients.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Endovascular repair of AAA</title>
		<link>http://www.cardiophile.net/2010/05/endovascular-repair-of-aaa.html</link>
		<comments>http://www.cardiophile.net/2010/05/endovascular-repair-of-aaa.html#comments</comments>
		<pubDate>Thu, 20 May 2010 15:58:58 +0000</pubDate>
		<dc:creator>Johnson Francis</dc:creator>
				<category><![CDATA[Angiography and Interventions]]></category>
		<category><![CDATA[Journal Update]]></category>
		<category><![CDATA[Peripheral]]></category>

		<guid isPermaLink="false">http://cardiophile.org/?p=4648</guid>
		<description><![CDATA[Endovascular repair of abdominal aortic aneurysm (AAA) is an evolving modality of treatment. Conventional repair of AAA was surgical. A recent study published in NEJM compared endovascular repair with open surgical repair. This randomized study involved over 1200 patients from 1999 to 2004 in 37 hospitals in the United Kingdom. They were followed up till [...]]]></description>
			<content:encoded><![CDATA[<p>Endovascular repair of abdominal aortic aneurysm (AAA) is an evolving modality of treatment. Conventional repair of AAA was surgical. A recent study published in <a href="http://content.nejm.org/cgi/content/short/362/20/1863?query=TOC">NEJM</a> compared endovascular repair with open surgical repair. This randomized study involved over 1200 patients from 1999 to 2004 in 37 hospitals in the United Kingdom. They were followed up till the end of 2009. Thirty day mortality was lower in the endovascular repair group (1.8%) compared to the open surgical repair group (4.3%). But the early mortality benefit was partially lost on follow up due to fatal endograft ruptures. There was no difference in all cause mortality between the two groups at the end of follow up. The study group concluded that endovascular repair was associated with graft related complications and re-interventions which were more costly. But this report is of patients who have undergone endovascular repair between 1999 and 2004. Technology has advanced much more since the earlier procedures in this group and this disadvantage is there for any study of long duration. By the time study is completed, the report will be that of an older technology, the results of which may not be equivalent to that of the current technology.</p>
<p>Another study published in the same issue of the journal also made similar conclusions.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cardiophile.net/2010/05/endovascular-repair-of-aaa.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug eluting balloon (DEB)</title>
		<link>http://www.cardiophile.net/2010/05/drug-eluting-balloon-deb.html</link>
		<comments>http://www.cardiophile.net/2010/05/drug-eluting-balloon-deb.html#comments</comments>
		<pubDate>Wed, 19 May 2010 15:52:35 +0000</pubDate>
		<dc:creator>Johnson Francis</dc:creator>
				<category><![CDATA[Angiography and Interventions]]></category>
		<category><![CDATA[Coronary]]></category>

		<guid isPermaLink="false">http://cardiophile.org/?p=4641</guid>
		<description><![CDATA[Drug eluting balloon (DEB) is an emerging method for combating restenosis in coronary and peripheral interventions. Paclitaxel is the primary drug in view of its rapid uptake and prolonged retention. Drug eluting ballons have been shown to be useful in patients with in-stemt restenosis. DEB has also been evaluated in small vessel disease, superficial femoral [...]]]></description>
			<content:encoded><![CDATA[<p>Drug eluting balloon (DEB) is an emerging method for combating restenosis in coronary and peripheral interventions. Paclitaxel is the primary drug in view of its rapid uptake and prolonged retention. Drug eluting ballons have been shown to be useful in patients with in-stemt restenosis. DEB has also been evaluated in small vessel disease, superficial femoral artery disease and below knee disease. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18360855">DEBIUT</a> (drug-eluting balloon in bifurcation Utrecht) registry evaluated the efficacy of DEB in bifurcation lesions. Twenty patients with bifurcation lesions enrolled in this registry underwent treatment with paclitaxel coated balloons and provisional stenting of the main branch with bare metal stent. There were no major acute coronary events or subacute vessel closure at 4 month follow up. DEB has also been used in <a href="http://www.ncbi.nlm.nih.gov/pubmed/20432403">treating vein graft disease along with a novel pericardium covered stent</a>. Pericardium covered stent was considered because of the poor crossing profile of PTFE covered stents. A study involving one hundred and thirty one patients with in-stent restenosis randomized between <a href="http://www.ncbi.nlm.nih.gov/pubmed/19487593">paclitaxel coated balloon and paclitaxel coated stent</a> found the parameters better with balloon, but not statistically significant. They authors concluded that a second stent is not required for inhibition of re-restenosis.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cardiophile.net/2010/05/drug-eluting-balloon-deb.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Percutaneous in situ coronary artery bypass (PICAB) and PICVA</title>
		<link>http://www.cardiophile.net/2010/05/percutaneous-in-situ-coronary-artery-bypass-picab.html</link>
		<comments>http://www.cardiophile.net/2010/05/percutaneous-in-situ-coronary-artery-bypass-picab.html#comments</comments>
		<pubDate>Wed, 12 May 2010 10:42:20 +0000</pubDate>
		<dc:creator>Johnson Francis</dc:creator>
				<category><![CDATA[Angiography and Interventions]]></category>
		<category><![CDATA[Coronary]]></category>

		<guid isPermaLink="false">http://cardiophile.org/?p=4544</guid>
		<description><![CDATA[Percutaneous in situ coronary artery bypass (PICAB) is a technique in which a conduit is created between a proximal coronary artery and a vein in order to supply oxygenated blood to a region of ischemic myocardium. The vein is entered from the artery proximal to the obstruction and the artery is re-entered from the vein [...]]]></description>
			<content:encoded><![CDATA[<p>Percutaneous in situ coronary artery bypass (PICAB) is a technique in which a conduit is created between a proximal coronary artery and a vein in order to supply oxygenated blood to a region of ischemic myocardium. The vein is entered from the artery proximal to the obstruction and the artery is re-entered from the vein distal to the obstruction. This segment of the vein acts as a bypass. The lumen of the vein is plugged before after this segment.</p>
<p>Myocardium is perfused through a coronary vein in a retrograde fashion in another procedure known as PICVA (Percutaneous In situ Coronary Venous Arterialization). In that procedure, a fistula is created from the artery proximal to the obstruction to the coronary vein using a self expanding connector. The proximal vein is plugged off to prevent steal of blood into the coronary sinus. This technique will force retroperfusion of the myocardium through the coronary vein. The procedure has been be done between proximal left anterior descending coronary artery and the anterior interventricular vein to perfuse the anterior wall in a case of diffuse left anterior descending artery disease with no other options <a href="http://circ.ahajournals.org/cgi/content/full/103/21/2539">http://circ.ahajournals.org/cgi/content/full/103/21/2539</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cardiophile.net/2010/05/percutaneous-in-situ-coronary-artery-bypass-picab.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>L-mode display in IVUS (intravscular ultrasound)</title>
		<link>http://www.cardiophile.net/2010/05/l-mode-display-in-ivus-intravscular-ultrasound.html</link>
		<comments>http://www.cardiophile.net/2010/05/l-mode-display-in-ivus-intravscular-ultrasound.html#comments</comments>
		<pubDate>Tue, 11 May 2010 16:15:11 +0000</pubDate>
		<dc:creator>Johnson Francis</dc:creator>
				<category><![CDATA[Angiography and Interventions]]></category>
		<category><![CDATA[Coronary]]></category>
		<category><![CDATA[Intravascular Ultrasound (IVUS)]]></category>

		<guid isPermaLink="false">http://cardiophile.org/?p=4542</guid>
		<description><![CDATA[L-mode display in IVUS (intravscular ultrasound) is a computerised reconstruction of a longitudinal section of the vessel using digitally stored images from a motorised pullback of the IVUS catheter. The cut plane should be selected through the center of the artery as the position of the catheter within the vessel can vary during the pullback. [...]]]></description>
			<content:encoded><![CDATA[<p>L-mode display in IVUS (intravscular ultrasound) is a computerised reconstruction of a longitudinal section of the vessel using digitally stored images from a motorised pullback of the IVUS catheter. The cut plane should be selected through the center of the artery as the position of the catheter within the vessel can vary during the pullback. A major limitation of the L-mode is that the vessel is displayed as a straight structure in the reconstruction while actually it is never so. More over, only a single cut plane can be shown in L-mode display. Another disadvantage is that the vessel size changes in various phases of the cardiac cycle. This can produce a &#8216;saw tooth&#8217; appearance, which is artifactual. Image acquisition in an electrocardiographically triggered mode can remove these artifacts.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cardiophile.net/2010/05/l-mode-display-in-ivus-intravscular-ultrasound.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Coronary Intravascular Ultrasound (IVUS)</title>
		<link>http://www.cardiophile.net/2010/05/coronary-intravascular-ultrasound-ivus.html</link>
		<comments>http://www.cardiophile.net/2010/05/coronary-intravascular-ultrasound-ivus.html#comments</comments>
		<pubDate>Tue, 11 May 2010 16:02:13 +0000</pubDate>
		<dc:creator>Johnson Francis</dc:creator>
				<category><![CDATA[Angiography and Interventions]]></category>
		<category><![CDATA[Coronary]]></category>
		<category><![CDATA[Intravascular Ultrasound (IVUS)]]></category>

		<guid isPermaLink="false">http://cardiophile.org/?p=4539</guid>
		<description><![CDATA[Coronary Intravascular Ultrasound (IVUS) consists of an IVUS catheter, pullback device and the imaging console. If lesion lengths have to be assessed, motorized pullback is required. For assessing lesion morphology a manual pullback can also be done. While manual pullback allows concentration on specific lesions, it may miss some lesions in between if the pullback [...]]]></description>
			<content:encoded><![CDATA[<p>Coronary Intravascular Ultrasound (IVUS) consists of an IVUS catheter, pullback device and the imaging console. If lesion lengths have to be assessed, motorized pullback is required. For assessing lesion morphology a manual pullback can also be done. While manual pullback allows concentration on specific lesions, it may miss some lesions in between if the pullback is not steady. Catheter has to be disengaged while evaluating coronary ostial lesions.</p>
<p>Heparin and intracoronary nitroglycerine are given before the guide wire is inserted after the coronary cannulation with a guide catheter. The IVUS catheter is then introduced over the guide wire. Images are continuously recorded by the system for later review and analysis.</p>
<h4>Measurements in IVUS</h4>
<p>Measurements in IVUS include the measurement of lumen, plaque, calcium, remodeling, stent, length and volumetric measurements.</p>
<h4>Plaque morphology</h4>
<p>Plaque morphology can be assessed in terms of its geometry and echogenicity. In the geometry, the size of the plaque, its relationship to luminal stenosis, arterial remodeling and eccentricity can be evaluated. Echogenicity could be regarding echolucent and echodense as well as calcified plaques. Thrombus and intimal hyperplasia can be noted. A vulnerable plaque and a plaque with ulceration or rupture can also be found.</p>
<h4>Important applications of IVUS</h4>
<p>Assessment of an angiographically indeterminate lesion, especially that of the left main coronary artery, is an important reason for an IVUS study. It can also guide guidance for stenting in terms of assessment of stent apposition and good expansion. IVUS can also delineate intramural hematoma and dissection.</p>
<h4>Artifacts in IVUS</h4>
<p>Artifacts are possible in an IVUS study due to guide wire artifacts, ring down artifacts, non-uniform rotational distortion, slow flow, coronary pulsation and motion, catheter obliquity and eccentricity and calcium shadow.</p>
<h4>Potential complications of an IVUS study</h4>
<p>Major complications are rare and could include dissection or vessel occlusion. But these major complications occur usually during interventions rather than diagnostic IVUS evaluations. Vasospasms are usually transient and respond to intracoronary nitroglycerine. Transient ischemia may occur while negotiating tight stenosis or small vessels. IVUS should be performed only by operators with significant experience in diagnostic and interventional procedures in the coronaries.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cardiophile.net/2010/05/coronary-intravascular-ultrasound-ivus.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interventions in the immediate new born period</title>
		<link>http://www.cardiophile.net/2010/05/interventions-in-the-immediate-new-born-period.html</link>
		<comments>http://www.cardiophile.net/2010/05/interventions-in-the-immediate-new-born-period.html#comments</comments>
		<pubDate>Sun, 09 May 2010 07:19:25 +0000</pubDate>
		<dc:creator>Johnson Francis</dc:creator>
				<category><![CDATA[Angiography and Interventions]]></category>
		<category><![CDATA[congenital]]></category>

		<guid isPermaLink="false">http://cardiophile.org/?p=4533</guid>
		<description><![CDATA[A newborn with a suspected cardiac problem is an emergency unless proved otherwise. When to suspect congenital heart disease in a new born? New born with difficulty in breathing, cyanosis, feeding difficulty, undue lethargy or undue irritability and insolable cry after feeding (suspect ALCAPA &#8211; anomalous origin of left coronary artery from pulmonary artery) are [...]]]></description>
			<content:encoded><![CDATA[<p>A newborn with a suspected cardiac problem is an emergency unless proved otherwise.</p>
<p><strong>When to suspect congenital heart disease in a new born?</strong></p>
<p>New born with difficulty in breathing, cyanosis, feeding difficulty, undue lethargy or undue irritability and insolable cry after feeding (suspect ALCAPA &#8211; anomalous origin of left coronary artery from pulmonary artery) are the situations in which congenital heart disease is suspected in a new born.</p>
<h4>Physical examination</h4>
<p>Physical examination is often difficult in a sick infant, but should include the assessment of pulse, respiration, colour, tone, activity, cry and murmurs. Occasionally a bounding pulse with heart failure and a large heart, but a normal echocardiogram (except for chamber dilatations), may be due the the vein of Galen aneurysm producing an arteriovenous shunting. Many infants may be branded as cardiomyopathy if a careful examination of femoral pulse is not performed to identify coarctation of aorta. Respiratory distress with increased effort as evidenced by a tracheal tug mandates ventilation. Pallor may be noted in heart failure and cyanosis in hypoxemia. Hypotonia with severe decrease in activity suggests a severe cardiac lesion. Please note that the absence of a murmur does not rule out severe congenital heart disease.</p>
<h4>Role of X-ray chest</h4>
<p>The x-ray chest is useful to know the state of the pulmonary blood flow, whether it is oligemic or plethoric. It is also useful for ruling out lung pathology and identifying the situs of the heart and the viscera. Oligemic lung field with a prominent main pulmonary artery segment would suggest tetralogy of Pulmonary artery with absent pulmonary valve. A large heart in a newborn should make us suspect Ebsteins anomaly of the tricuspid valve or a critical pulmonary stenosis with heart failure. Agenesis of the lung, collapse of the lung, eventration of the diaphragm and diaphragmatic hernia may be seen on the chest x-ray.</p>
<h4>Hyperoxia test</h4>
<p>Oxygen may be given with a hood or mask for 1 minutes, evaluating the blood before and after 100% oxygen. Saturation, PO2 and PCO2 are checked before and after the hyperoxia test. The test is useful in differentiating cyanotic congenital heart disease from lung disease.</p>
<h5>Concerns against a hyperoxia test:</h5>
<p>There is some concern over the induction of an irreversible ductal spasm in a ductus dependent new born, though it is extremely uncommon. Ductal spasm can also occur even without oxygen administration. Ideally PGE1 should be available to tackle duct spasm.</p>
<h4>Pulse oximetry in the new born</h4>
<p>Pulsoximetry should be done in all four limbs as desaturation may be there only in the lower limbs in certain situations. Obtaining a good pulsoximetry may not be easy in a sick infant. The limbs should be warm to avoid errors. The visual and auditory signals associated with pulsoximetry should be good. A good plethysmograph ensures accuracy of the technique.</p>
<h4>Role of ECG</h4>
<p>Arrhythmias causing tachycardiomyopathy may be occasionally identified in a new born with heart failure. New born hearts are extremely prone for heart failure with prolonged tachyarrhythmias. Big Q waves in lateral leads could suggest ALCAPA.</p>
<h4>Role of echocardiography</h4>
<p>Echocardiography is the most important diagnostic tool in a new born with suspected congenital heart disease. A systematic and segmental approach is essential to avoid missing important lesions. The coronaries should be specifically looked for. Optimum machine which is dedicated to echocardiography with a good neonatal probe is ideal. There is no need to emphasise the need for trained personnel. If a coarctation is not seen from the suprasternal or parasternal views, an epigastric view might demonstrate a coarctation of the abominal aorta. Other lesions which can be easily missed are infra diaphragmatic TAPVC (total anomalous pulmonary venous connection) and coarctation in the presence of a PDA (patent ductus arteriosus). Repeat echoes and second opinions are needed in difficult cases.</p>
<h4>Role of computerised tomography (CT)</h4>
<p>CT is useful in the differentiation of coarctation of aorta from aortic arch interruptions. Pulmonary venous drainage in heterotaxy may also be better seen on CT.</p>
<h4>Cardiac emergencies in the newborn</h4>
<p>They may present with severe hypoxia, severe heart failure or cardiovascular collapse. This could be because the anatomical lesions are critical or because of associated complications like pneumonia, gastroenteritis or anemia. These infants are very sick and need rapid triage and management.</p>
<h4>Treatment of emergencies in infants with trans catheter techniques</h4>
<p>Treatment of emergencies require a good team work of experts, good imaging and a large inventory of hardware with preferably no constraints of cath lab time or money. The expert team is composed of intensivists, anaesthetists, nurses, technicians, cardiac surgeons and the interventional cardiologists. New born emergencies are very sick with associated hypoxia, acidosis, dehydration, hypoglycemia and electrolyte imbalance. They have poor ventricular function and a low safety margin. Failed procedure in this situation would mean a higher mortality than not attempting the procedure at all.</p>
<p>The protocol is to stabilise initially in a new born intensive care unit (NICU) and then optimally time the intervention &#8211; not too early or too late. Attention has to be made to baseline parameters, airway and ventilation, intravenous access, blood investigations, hydration, correction of anemia, acidosis and electrolyte imbalance. Echocardiography and screening for clotting abnormalities are needed.</p>
<p>Once the vascular access for intervention is obtained, it is almost like half the work done. Care with contrast injection is needed to avoid cardiac and renal dysfunction in the sick neonate.</p>
<h4>Interventional procedures in the newborn</h4>
<p>Dilatation of valves &#8211; balloon aortic valvuloplasty (BPV), balloon pulmonary valvuloplasty</p>
<p>Perforation of valves &#8211; pulmonary valve in pulmonary atresia</p>
<p>Dilatation of vessels &#8211; coarctation of aorta</p>
<p>Maintaining ductal patency &#8211; stenting of the duct</p>
<p>Closure of PDA with coil or device</p>
<p>Balloon atrial septostomy</p>
<p>Embolisation of accessory channels as vein of Galen aneurysm or in Scimitar syndrome</p>
<p>Balloon atrial septostomy may even be done in the neonatal ICU in very sick infants under echo guidance. Fetal diagnosis may enable tackling of the lesion on day 1 itslef. Neonatal BPV can be done with coronary guide wires and balloons. Perforation of the atretic valve in pulmonary atresia may be done with the hard end of a guide wire. The perforation is crossed with a coronary wire and serially dilated with coronary balloons. Sometimes the perforation is also stented, though it will produce significant pulmonary regurgitation. Critical aortic stenosis can also be dilated similarly. Severe coarctation can also be dilated, though it may be a palliative procedure as a bridge to surgery. Dilatation with or without stenting for an occluded Blalock Taussig shunt is another trans catheter procedure. Recurrence is likely and needs a more definitive treatment.</p>
<h4>Hybrid procedures in the new born</h4>
<p>Hybrid procedures can be done either in the operating room or in hybrid suites. In closing a muscular VSD in a sick neonate not suitable for cardiopulmonary bypass, after sternotomy, the right ventricle is punctured and a guide wire is passed across the VSD. The sheath is then threaded over it followed by device delivery.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cardiophile.net/2010/05/interventions-in-the-immediate-new-born-period.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
